The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis

被引：0
|
作者：
Anan Gong
Xiaofei Li
机构：
[1] YiWu Central Hospital,Department of Hepatobiliary Surgery
[2] YiWu Central Hospital,Department of Infectious Diseases
来源：
World Journal of Surgical Oncology | / 20卷
关键词：
Apatinib; TACE; Liver; Cancer; Treatment; Effect; Safety; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis
    Ni, Jia-yan
    Liu, Shan-shan
    Xu, Lin-feng
    Sun, Hong-liang
    Chen, Yao-ting
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 653 - 659
  • [42] Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma
    Liu, Wenbin
    Xie, Zhiguo
    Shen, Kefeng
    Jiang, Lizhu
    Liu, Chongyan
    Ge, Yongsheng
    Yu, Jihai
    Jia, Weidong
    Ma, Jinliang
    Chen, Hao
    MEDICAL ONCOLOGY, 2023, 40 (09)
  • [43] Efficacy and safety of transarterial chemoembolization (TACE) plus apatinib as compared with TACE alone for recurrent hepatocellular carcinoma: A prospective randomized controlled trial
    Gu, H.
    Li, J.
    You, N.
    Wu, K.
    Wang, Z.
    Wang, L.
    Zhu, Y.
    Liu, Q.
    Peng, X.
    Zheng, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S219 - S220
  • [44] Efficacy and safety analysis of TACE + Donafenib + Toripalimab versus TACE + Sorafenib in the treatment of unresectable hepatocellular carcinoma: a retrospective study
    Haohao Lu
    Bin Liang
    Xiangwen Xia
    Chuansheng Zheng
    BMC Cancer, 23
  • [45] Original Comparison of efficacy and safety between transarterial chemoembolization (TACE) combined with lenvatinib versus TACE combined with sorafenib in the treatment of intermediate and advanced hepatocellular carcinoma
    Xu, Rui
    Ji, Xuebing
    Pei, Xiaohong
    Yu, Yongqiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (02): : 1117 - 1128
  • [46] EFFICACY AND SAFETY OF APATINIB COMBINED WITH GP REGIMEN IN THE TREATMENT OF RECURRENT NASOPHARYNGEAL CARCINOMA
    Luo, Tao
    Shang, Haihui
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 511 - 516
  • [47] Meta-analysis of the Efficacy of Sorafenib for Hepatocellular Carcinoma
    Wang, Zhao
    Wu, Xiao-Ling
    Zeng, Wei-Zheng
    Xu, Gui-Sen
    Xu, Hui
    Weng, Min
    Hou, Juan -Ni
    Jiang, Ming-De
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (02) : 691 - 694
  • [48] Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
    Gupta, Nandini
    Verma, Neelkant
    Patel, Bhoomika
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (04) : 1485 - 1497
  • [49] A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
    Huang, Shenglan
    Li, Dan
    Zhuang, LingLing
    Sun, Liying
    Wu, Jianbing
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [50] A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
    Shenglan Huang
    Dan Li
    LingLing Zhuang
    Liying Sun
    Jianbing Wu
    World Journal of Surgical Oncology, 19
12345